Inhibitory effects of cigarette smoke on glial inducible nitric oxide synthase and lack of protective properties against oxidative neurotoxins in vitro

NeuroToxicology

Volumn 26, Issue 1, 2005, Pages 49-62

  Mazzio, Elizabeth A ^a   Kolta, Malak G ^a   Reams, R Renee ^a   Soliman, Karam F A ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Cigarettes; Monoamine oxidase; MPP +; Nitric oxide; Parkinson's disease; Smoking

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CIGARETTE SMOKE CONDENSATE; CYTOKINE; ENDOTOXIN; HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEUROTOXIN; NITRIC OXIDE; OXIDOPAMINE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME KINETICS; EVALUATION; GLIOMA CELL; MEDICAL RESEARCH; NEUROBLASTOMA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; GLIOMA; HYDROGEN PEROXIDE; MONOAMINE OXIDASE; NEUROBLASTOMA; NEUROGLIA; NEUROTOXINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; OXIDANTS; OXIDOPAMINE; PYRIDINIUM COMPOUNDS; RATS; SMOKE; SMOKING; SYMPATHOLYTICS;

GYMNOMYZA SAMOENSIS;

EID: 7444233703     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2004.07.005     Document Type: Article

References (99)

1. A. Alberg The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients Toxicology 180 2002 121 133
2. D.J. Balfour, and K.O. Fagerstrom Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders Pharmacol. Ther. 72 1996 51 81
3. M. Behari, A.K. Srivastava, R.R. Das, and R.M. Pandey Risk factors of Parkinson's disease in Indian patients J. Neurol. Sci. 190 2001 49 55
4. I. Berlin, O. Spreux-Varoquaux, and J.M. Launay Platelet monoamine oxidase B activity is inversely associated with plasma cotinine concentration Nicotine Tob Res. 2 2000 243 246
5. D. Blum, S. Torch, M.F. Nissou, A.L. Benabid, and J.M. Verna Extracellular toxicity of 6-hydroxydopamine on PC12 cells Neurosci. Lett. 283 2000 193 196
6. D. Blum, S. Torch, N. Lambeng, M. Nissou, A.L. Benabid, R. Sadoul, and J.M. Verna Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Prog. Neurobiol. 65 2001 135 172
7. P. Bornemisza, and I. Suciu Effect of cigarette smoking on the blood glucose level in normal and diabetics Med. Int. 18 1980 353 356
8. H. Broholm, B. Andersen, B. Wanscher, J.L. Frederiksen, I. Rubin, B. Pakkenberg, H.B. Larsson, and M. Lauritzen Nitric oxide synthase expression and enzymatic activity in multiple sclerosis Acta Neurol. Scand. 109 2004 261 269
9. G.C. Brown, and V. Borutaite Nitric oxide inhibition of mitochondrial respiration and its role in cell death Free Radic Biol. Med. 33 2002 1440 1450
10. S. Canals, M.J. Casarejos, E. Rodriguez-Martin, S. de Bernardo, and M.A. Mena Neurotrophic and neurotoxic effects of nitric oxide on fetal midbrain cultures J. Neurochem. 76 2001 56 68
11. L.A. Carr, and J.K. Basham Effects of tobacco smoke constituents on MPTP-induced toxicity and monoamine oxidase activity in the mouse brain Life Sci. 48 1991 1173 1177
12. +-induced apoptosis depends on mitochondrial membrane potential and ATP synthase Biochem. Biophys. Res. Commun. 257 1999 440 447
13. L.J. Chandler, K. Kopnisky, E. Richards, F.T. Crews, and C. Sumners Angiotensin II decreases inducible nitric oxide synthase expression in rat astroglial cultures Am. J. Physiol. 268 1995 C700 C707
14. R.S. Clark, P.M. Kochanek, W.D. Obrist, H.R. Wong, T.R. Billiar, S.R. Wisniewski, and D.W. Marion Cerebrospinal fluid and plasma nitrite and nitrate concentrations after head injury in humans Crit. Care Med. 24 1996 1243 1251
15. G. Costa, J.A. Abin-Carriquiry, and F. Dajas Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra Brain Res. 888 2001 336 342
16. J.A. Court, M.A. Piggott, S. Lloyd, N. Cookson, C.G. Ballard, I.G. McKeith, R.H. Perry, and E.K. Perry Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication Neuroscience 98 2000 79 87
17. G. De Michele, A. Filla, G. Volpe, V. De Marco, A. Gogliettino, G. Ambrosio, R. Marconi, A.E. Castellano, and G. Campanella Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy Mov. Disord. 11 1996 17 23
18. L.W. Dobrucki, L. Kalinowski, W. Uracz, and T. Malinski The protective role of nitric oxide in the brain ischemia J. Physiol. Pharmacol. 51 2000 695 703
19. M. Ebadi, R. Govitrapong, S. Sharma, D. Muralikrishnan, S. Shavali, L. Pellett, R. Schafer, C. Albano, and J. Eken Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of Parkinson's disease Biol. Signals Receptor 10 2001 224 253
20. S.M. Evans, A. Casartelli, E. Herreros, D.T. Minnick, C. Day, E. George, and C. Westmoreland Development of a high throughput in vitro toxicity screen predictive of high acute in vivo toxic potential Toxicol. In Vitro 15 2001 579 584
21. E. Ferruzzi, R. Franceschini, G. Cazzolato, C. Geroni, C. Fowst, U. Pastorino, N. Tradati, J. Tursi, R. Dittadi, and M. Gion Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neck Eur. J. Cancer 39 2003 1019 1029
22. J.S. Fowler, N.D. Volkow, G.J. Wang, J. Logan, N. Pappas, C. Shea, and R. MacGregor Age-related increases in brain monoamine oxidase B in living healthy human subjects Neurobiol. Aging 18 1997 431 435
23. J.S. Fowler, N.D. Volkow, G.J. Wang, N. Pappas, J. Logan, R. MacGregor, D. Alexoff, A.P. Wolf, D. Warner, R. Cilento, and I. Zezulkova Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition J. Addict Dis. 17 1998 23 34
24. J.W. Foy, B.R. Bombick, D.W. Bombick, D.J. Doolittle, A.T. Mosberg, and J.E. Swauger A comparison of in vitro toxicities of cigarette smoke condensate from Eclipse cigarettes and four commercially available ultra low-"tar" cigarettes Food Chem. Toxicol. 42 2004 243 249
25. L. Fratiglioni, and H.X. Wang Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies Behav. Brain Res. 113 2000 117 120
26. C. Gahm, S. Holmin, and T. Mathiesen Nitric oxide synthase expression after human brain contusion Neurosurgery 50 2002 1319 1326
27. J.L. Goodwin, E. Uemura, and J.E. Cunnick Microglial release of nitric oxide by the synergistic action of beta-amyloid and IFN-gamma Brain Res. 692 1995 207 214
28. J.M. Gorell, B.A. Rybicki, C.C. Johnson, and E.L. Peterson Smoking and Parkinson's disease: a dose response relationship Neurology 52 1999 115 119
29. J. Haorah, L. Zhou, X. Wang, G. Xu, and S.S. Mirvish Determination of total N-nitroso compounds and their precursors in frankfurters, fresh meat, dried salted fish, sauces, tobacco, and tobacco smoke particulates J. Agric. Food Chem. 49 2001 6068 6078
30. S.S. Hecht, C.B. Chen, R.M. Ornaf, D. Hoffmann, and T.C. Tso Chemical studies on tobacco smoke LVI. Tobacco specific nitrosamines: origins, carcinogenicity and metabolism IARC Sci. Publ. 19 1978 395 413
31. Y.O. Herishanu, M. Medvedovski, J.R. Goldsmith, and E. Kordysh A case-control study of Parkinson's disease in urban population of southern Israel Can. J. Neurol. Sci. 28 2001 144 147
32. M.A. Hernan, S.M. Zhang, A.M. Rueda-deCastro, G.A. Colditz, F.E. Speizer, and A. Ascherio Cigarette smoking and the incidence of Parkinson's disease in two prospective studies Ann. Neurol. 50 2001 776 780
33. A. Holt, D.F. Sharman, G.B. Baker, and M.M. Palcic A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates Anal. Biochem. 244 1997 384 392
34. Y. Hotta, H. Otsuka-Murakami, M. Fujita, J. Nakagawa, M. Yajima, W. Liu, N. Ishikawa, N. Kawai, T. Masumizu, and M. Kohno Protective role of nitric oxide synthase against ischemia-reperfusion injury in guinea pig myocardial mitochondria Eur. J. Pharmacol. 380 1999 37 48
35. D.H. Hyun, M. Lee, N. Hattori, S. Kubo, Y. Mizuno, B. Halliwell, and P. Jenner Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome J. Biol. Chem. 277 2002 28572 28577
36. G. Jeyarasasingam, L. Tompkins, and M. Quik Stimulation of non-alpha7 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture Neuroscience 109 2002 275 285
37. M.C. Kelton, H.J. Kahn, C.L. Conrath, and P.A. Newhouse The effects of nicotine on Parkinson's disease Brain Cogn. 43 2000 274 282
38. K. Kikugawa, K. Hiramoto, and T. Ohkawa Effects of oxygen on the reactivity of nitrogen oxide species including peroxynitrite Biol. Pharm. Bull. 27 2004 17 23
39. J.M. Kulak, J.L. Musachio, J.M. McIntosh, and M. Quik Declines in different beta2* nicotinic receptor populations in monkey striatum after nigrostriatal damage J. Pharmacol. Exp. Ther. 303 2002 633 639
40. N. Le Novere, M. Zoli, and J.P. Changeux Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain Eur. J. Neurosci. 8 1996 2428 2439
41. M. Lee, M. Wrensch, and R. Miike Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area (California, USA) Cancer Causes Control 8 1997 13 24
42. S.W. Li, T.S. Lin, S. Minteer, and W.J. Burke 3,4- Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: Possible role in Parkinson's disease pathogenesis Brain Res. Mol. Brain Res. 93 2001 1 7
43. W. Linert, M.H. Bridge, M. Huber, K.B. Bjugstad, S. Grossman, and G.W. Arendash In vitro and in vivo studies investigating possible antioxidant actions of nicotine: relevance to Parkinson's and Alzheimer's diseases Biochim. Biophys. Acta 1454 1999 143 152
44. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with Folin phenol reagent J. Biol. Chem. 193 1951 265 275
45. H.J. Luth, G. Munch, Arendt J. Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation Brain Res. 953 2002 135 143
46. R. Maggio, M. Riva, F. Vaglini, F. Fornai, G. Racagni, and G.U. Corsini Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism Neural. Transm. 104 1997 1113 1123
47. W. Maruyama, K. Sango, K. Iwasa, C. Minami, P. Dostert, M. Kawai, M. Moriyasu, and M. Naoi Dopaminergic neurotoxins. 6,7-dihydroxy-1-(3′, 4′-dihydroxybenzyl)-isoquinolines, cause different types of cell death in SH-SY5Y cells: apoptosis was induced by oxidized papaverolines and necrosis by reduced tetrahydropapaverolines Neurosci. Lett. 291 2000 89 92
48. W. Maruyama Pathogenesis of idiopathic Parkinson's disease Nippon Ronen Igakkai Zasshi 38 2001 494 497
49. W. Maruyama, Y. Akao, M.B. Youdim, B.A. Davis, and M. Naoi Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol J. Neurochem. 78 2001 727 735
50. R.B. Mason, R.M. Pluta, S. Walbridge, D.A. Wink, E.H. Oldfield, and R.J. Boock Production of reactive oxygen species after reperfusion in vitro and in vivo: protective effect of nitric oxide J. Neurosurg. 93 2000 99 107
51. E. Mazzio, and K.F.A. Soliman d-(+)-Glucose rescue against 1-methyl-4-phenylpyridinium toxicity through anaerobic glycolysis in neuroblastoma cells Brain Res. 962 2003 48 60
52. E. Mazzio, and K.F.A. Soliman Pyruvic acid cytoprotection against 1-methyl-4-phenylpyridinium, 6-hydroxydopamine and hydrogen peroxide toxicities in vitro Neurosci. Lett. 337 2003 77 80
53. E. Mazzio, A. Becker, and K.F. Soliman Inflammation and inducible nitric oxide synthase have no effect on monoamine oxidase activity in glioma cells Biochem. Pharmacol. 65 2003 1719 1727
54. E.A. Mazzio, R.R. Reams, and K.F. Soliman The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro Brain Res. 1004 2004 29 44
55. S.E. Moriarty, J.H. Shah, M. Lynn, S. Jiang, K. Openo, D.P. Jones, and P. Sternberg Oxidation of glutathione and cysteine in human plasma associated with smoking Free Radic. Biol. Med. 35 2003 1582 1588
56. J. Murray, S.W. Taylor, B. Zhang, S.S. Ghosh, and R.A. Capaldi Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry J. Biol. Chem. 278 2003 37223 37230
57. N. Nakanishi, K. Nakamura, Y. Matsuo, K. Suzuki, and K. Tatara Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men Ann. Int. Med. 133 2000 183 191
58. M. Naoi, and W. Maruyama Future of neuroprotection in Parkinson's disease Parkinsonism Relat. Disord. 8 2001 139 145
59. M. Naoi, W. Maruyama, T. Kasamatsu, and P. Dostert Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines J. Neural. Transm. Suppl. 52 1998 125 138
60. M. Naoi, W. Maruyama, T. Takahashi, Y. Akao, and Y. Nakagawa Involvement of endogenous N-methyl(R)salsolinol in Parkinson's disease: induction of apoptosis and protection by (-)deprenyl J. Neural. Transm. Suppl. 58 2000 111 121
61. M. Naoi, W. Maruyama, M.B. Youdim, P. Yu, and A.A. Boulton Anti-apoptotic functions of propargylamine inhibitors of type-B monoamine oxidase Inflammopharmacology 11 2003 175 181
62. K. Nara, D. Konno, J. Uchida, Y. Kiuchi, and K. Oguchi Protective effect of nitric oxide against iron-induced neuronal damage J. Neural. Transm. 106 1999 835 848
63. D.C. Paik, and J. Dillon The nitrite/alpha crystalline reaction: a possible mechanism in lens matrix damage Exp. Eye Res. 70 2000 73 80
64. K. Parain, C. Hapdey, E. Rousselet, V. Marchand, B. Dumery, and E.C. Hirsch Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin Brain Res. 984 2003 224 232
65. S.K. Park, and S. Murphy Duration of expression of inducible nitric oxide synthase in glial cells J. Neurosci. Res. 39 1994 405 411
66. Z.C. Peng, C. Pietra, A. Sbarbati, L. Ziviani, X.B. Yan, F. Osculati, and M. Bentivoglio Induction of NADPH-diaphorase activity in the rat forebrain after middle cerebral artery occlusion Exp. Neurol. 138 1996 105 120
67. P.G. Persson, S. Carlsson, L. Svanstrom, C.G. Ostenson, S. Efendic, and V. Grill Cigarette smoking, oral moist snuff use and glucose intolerance J. Int. Med. 248 2000 103 110
68. S.L. Pimlott, M. Piggott, J. Owens, E. Greally, J.A. Court, E. Jaros, R.H. Perry, E.K. Perry, and D. Wyper Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380 Neuropsychopharmacology 29 2004 108 116
69. N. Pizzinat, N. Copin, C. Vindis, A. Parini, and C. Cambon Reactive oxygen species production by monoamine oxidases in intact cells Naunyn Schmiedebergs Arch. Pharmacol. 359 1999 428 431
70. P.M. Preux, A. Condet, C. Anglade, M. Druet-Cabanac, C. Debrock, W. Macharia, P. Couratier, F. Boutros-Toni, and M. Dumas Parkinson's disease and environmental factors. Matched case-control study in the Limousin region, France Neuroepidemiology 19 2000 333 337
71. W.A. Pryor, and K. Stone Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite Ann. N.Y. Acad. Sci. 686 1993 27 28
72. M. Quik, and G. Jeyarasasingam Nicotinic receptors and Parkinson's disease Eur. J. Pharmacol. 393 2000 223 230
73. M. Quik, and J.M. Kulak Nicotine and nicotinic receptors; relevance to Parkinson's disease Neurotoxicology 23 2002 581 594
74. M. Quik, Y. Polonskaya, A. Gillespie, M. Jakowec, G.K. Lloyd, and J.W. Langston Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization J. Comp. Neurol. 425 2000 58 69
75. M. Quik, Y. Polonskaya, J.M. Kulak, and J.M. McIntosh Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey J. Neurosci. 1 21 2001 5494 5500
76. S. Reddy, E.I. Finkelstein, P.S. Wong, A. Phung, C.E. Cross, and A. van der Vliet Identification of glutathione modifications by cigarette smoke Free Radic. Biol. Med. 33 2002 1490 1498
77. J. Rincon, A. Krook, D. Galuska, H. Wallberg-Henriksson, and J.R. Zierath Altered skeletal muscle glucose transport and blood lipid levels in habitual cigarette smokers Clin. Physiol. 19 1999 135 142
78. H. Rommelspacher, M. Meier-Henco, M. Smolka, and C. Kloft The levels of norharman are high enough after smoking to affect monoamine oxidase B in platelets Eur. J. Pharmacol. 441 2002 115 125
79. G.W. Ross, and H. Petrovitch Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease Drugs Aging 18 2001 797 806
80. K. Rustemeier, R. Stabbert, H.J. Haussmann, E. Roemer, and E.L. Carmines Evaluation of the potential effects of ingredients added to cigarettes. Part 2: chemical composition of mainstream smoke Food Chem. Toxicol. 40 2002 93 104
81. R.E. Ryan, S.A. Ross, and J. Drago Loiacono RE.Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice Br. J. Pharmacol. 132 2001 1650 1656
82. + and Rotenone in Neural Cell Lines The Toxicologist 11 1991 313
83. Y. Skurnik, and Y. Shoenfeld Health effects of cigarette smoking Clin. Dermatol. 16 1998 545 556
84. R. Soto-Otero, E. Mendez-Alvarez, R. Riguera-Vega, E. Quinoa-Cabana, I. Sanchez-Sellero, and M. Lopez-Rivadulla Lamas Studies on the interaction between 1,2,3,4-tetrahydro-beta-carboline and cigarette smoke: a potential mechanism of neuroprotection for Parkinson's disease Brain Res. 802 1998 155 162
85. R. Soto-Otero, E. Mendez-Alvarez, A. Hermida-Ameijeiras, A.M. Munoz-Patino, and J.L. Labandeira-Garcia Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease J. Neurochem. 74 2000 1605 1612
86. R. Soto-Otero, E. Mendez-Alvarez, I. Sanchez-Sellero, A. Cruz-Landeira, and M. Lopez-Rivadulla Lamas Reduction of rat brain levels of the endogenous dopaminergic proneurotoxins 1,2,3,4-tetrahydroisoquinoline and 1,2,3,4-tetrahydro-beta-carboline by cigarette smoke Neurosci. Lett. 298 2001 187 190
87. R.F. Squires Discovery of monoamine oxidase forms A and B Vopr Med. Khim. 43 1997 433 439
88. A. Storch, A. Kaftan, K. Burkhardt, and J. Schwarz 1-Methyl-6,7- dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism Brain Res. 855 2000 67 75
89. C. Szabo Multiple pathways of peroxynitrite cytotoxicity Toxicol. Lett. 140-141 2003 105 112
90. B.J. Tabner, S. Turnbull, O.M. El-Agnaf, and D. Allsop Formation of hydrogen peroxide and hydroxyl radicals from A beta and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease Free Radic. Biol. Med. 32 2002 1076 1083
91. T. Tokimoto, and K. Shinagawa Nitric oxide generation in aqueous solutions of cigarette smoke and approaches to its origin Biol. Chem. 382 2001 1613 1619
92. M. Tsuchiya, A. Asada, E. Kasahara, E.F. Sato, M. Shindo, and M. Inoue Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma Circulation 105 2002 1155 1157
93. D. Venarucci, V. Venarucci, A. Vallese, L. Battila, A. Casado, J De la Torre, and ME Lopez Fernandez Free radicals: important cause of pathologies refers to ageing Panminerva Med. 41 1999 335 339
94. H. Vieira, and G. Kroemer Mitochondria as targets of apoptosis regulation by nitric oxide IUBMB Life 55 2003 613 616
95. N.D. Volkow, J.S. Fowler, Y.S. Ding, G.J. Wang, and S.J. Gatley Imaging the neurochemistry of nicotine actions: studies with positron emission tomography Nicotine Tob. Res. Suppl. 2 1999 S127 S132 D S139-140
96. Y. Yamaguchi, S. Matsuno, S. Kagota, J. Haginaka, and M. Kunitomo Peroxynitrite-mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin Atherosclerosis 172 2004 259 265
97. M.B. Youdim, and L. Lavie Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's disease Life Sci. 55 1994 2077 2082
98. Y.C. Zeng, S. Bongrani, E. Bronzetti, S. Cadel, A. Ricci, B. Valsecchi, and F. Amenta Effect of long-term treatment with l-deprenyl on the age-dependent microanatomical changes in the rat hippocampus Mech. Ageing Dev. 79 1995 169 185
99. M.L. Zhao, J.S. Liu, D. He, D.W. Dickson, and S.C. Lee Inducible nitric oxide synthase expression is selectively induced in astrocytes isolated from adult human brain Brain Res. 813 1998 402 405